that's a good question. we haven't a clue if any "big pharma" is remotely interested or if there have been several offers that McColl has rejected on our behalf.
It's like selling a house where the real estate agent refuses to tell you what enquiries they've have.
...
The good news is that our Aussie dollar is falling, so any deal in US dollars will be even more attractive.
How do we know McColl is a good deal-maker? Can someone please ask that question at the AGM!
I can't even remember when an Australian biotech did a good deal. PXS?
Add to My Watchlist
What is My Watchlist?